VERV Verve Therapeutics | $4.12
+26.4% | 4/14/2025 | Target Raised by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $15.00 -> $25.00 | High | View details for HC Wainwright rating of Verve Therapeutics (NASDAQ:VERV) on 4/14/2025 |
FLD FTAC Emerald Acquisition | $3.24
+20.4% | 4/14/2025 | Reiterated by | HC Wainwright | Analyst K. Dede | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of FTAC Emerald Acquisition (NASDAQ:FLD) on 4/14/2025 |
ATEC Alphatec | $10.18
+4.4% | 4/14/2025 | Reiterated by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $20.00 -> $20.00 | High | View details for HC Wainwright rating of Alphatec (NASDAQ:ATEC) on 4/14/2025 |
TNGX Tango Therapeutics | $1.34
-5.0% | 4/14/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of Tango Therapeutics (NASDAQ:TNGX) on 4/14/2025 |
PYPD PolyPid | $2.55
+2.8% | 4/14/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 4/14/2025 |
IPA ImmunoPrecise Antibodies | $0.46
+6.0% | 4/11/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for HC Wainwright rating of ImmunoPrecise Antibodies (NASDAQ:IPA) on 4/11/2025 |
BTCM BIT Mining | $1.41
+2.5% | 4/11/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Neutral -> Neutral | | Low | View details for HC Wainwright rating of BIT Mining (NYSE:BTCM) on 4/11/2025 |
RR Richtech Robotics | $2.00
+2.0% | 4/11/2025 | Initiated by | HC Wainwright | Analyst Scott Buck | Buy | $3.50 | High | View details for HC Wainwright rating of Richtech Robotics (NASDAQ:RR) on 4/11/2025 |
WRN Western Copper & Gold | $1.13
+4.6% | 4/11/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $4.25 -> $4.25 | High | View details for HC Wainwright rating of Western Copper & Gold (NYSE:WRN) on 4/11/2025 |
CADL Candel Therapeutics | $5.17
+4.0% | 4/11/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $19.00 -> $19.00 | Low | View details for HC Wainwright rating of Candel Therapeutics (NASDAQ:CADL) on 4/11/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
UNCY Unicycive Therapeutics | $0.61
+11.4% | 4/11/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $7.50 -> $7.50 | Medium | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 4/11/2025 |
PTGX Protagonist Therapeutics | $45.03
+5.7% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $80.00 -> $80.00 | Low | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 4/10/2025 |
ARCT Arcturus Therapeutics | $10.18
+4.9% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $60.00 -> $60.00 | High | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 4/10/2025 |
INZY Inozyme Pharma | $0.97
+9.4% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $16.00 -> $16.00 | Medium | View details for HC Wainwright rating of Inozyme Pharma (NASDAQ:INZY) on 4/10/2025 |
EXK Endeavour Silver | $4.09
+3.8% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $7.25 -> $7.25 | Medium | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 4/10/2025 |
EOLS Evolus | $10.27
+7.7% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $27.00 -> $27.00 | High | View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 4/10/2025 |
TPST Tempest Therapeutics | $6.96
+11.9% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Neutral | $16.00 -> $16.00 | Medium | View details for HC Wainwright rating of Tempest Therapeutics (NASDAQ:TPST) on 4/10/2025 |
MBOT Microbot Medical | $2.28
+2.2% | 4/10/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $9.00 -> $9.00 | High | View details for HC Wainwright rating of Microbot Medical (NASDAQ:MBOT) on 4/10/2025 |
VALN Valneva | $7.05
+12.1% | 4/9/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $17.00 -> $17.00 | High | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 4/9/2025 |
FTCI FTC Solar | $2.68
-6.3% | 4/8/2025 | Target Raised by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $1.50 -> $5.00 | High | View details for HC Wainwright rating of FTC Solar (NASDAQ:FTCI) on 4/8/2025 |
ARGX argenx | $606.39
+4.4% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $720.00 -> $720.00 | High | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 4/8/2025 |
WPRT Westport Fuel Systems | $2.95
+2.8% | 4/9/2025 | Target Lowered by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $22.00 -> $7.00 | High | View details for HC Wainwright rating of Westport Fuel Systems (NASDAQ:WPRT) on 4/9/2025 |
VTVT vTv Therapeutics | $19.36
+3.1% | 4/9/2025 | Initiated by | HC Wainwright | Analyst Emily Bodnar | Buy | $36.00 | Medium | View details for HC Wainwright rating of vTv Therapeutics (NASDAQ:VTVT) on 4/9/2025 |
CASI CASI Pharmaceuticals | $2.10
+7.6% | 4/9/2025 | Target Lowered by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $6.00 -> $4.00 | High | View details for HC Wainwright rating of CASI Pharmaceuticals (NASDAQ:CASI) on 4/9/2025 |
RICK RCI Hospitality | $38.06
+2.4% | 4/9/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $98.00 -> $98.00 | High | View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 4/9/2025 |
RLYB Rallybio | $0.27
+8.0% | 4/9/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Neutral | | Low | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 4/9/2025 |
RNAC Cartesian Therapeutics | $13.00
+21.8% | 4/9/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 4/9/2025 |
BNGO Bionano Genomics | $4.82
+6.6% | 4/9/2025 | Initiated by | HC Wainwright | Analyst Yi Chen | Buy | $10.00 | High | View details for HC Wainwright rating of Bionano Genomics (NASDAQ:BNGO) on 4/9/2025 |
GMAB Genmab A/S | $19.32
+2.7% | 4/9/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $50.00 -> $37.00 | High | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 4/9/2025 |
IONS Ionis Pharmaceuticals | $28.68
+2.8% | 4/7/2025 | Upgraded by | HC Wainwright | Analyst M. Kapoor | Strong-Buy | $45.00 | High | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/7/2025 |
HRMY Harmony Biosciences | $29.53
+1.2% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst P. Trucchio | Buy -> Buy | $70.00 -> $70.00 | Medium | View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 4/8/2025 |
VYGR Voyager Therapeutics | $3.19
+0.6% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 4/8/2025 |
NYXH Nyxoah | $5.98
-2.8% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Nyxoah (NASDAQ:NYXH) on 4/8/2025 |
CLNN Clene | $3.08
+1.7% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $31.00 -> $31.00 | High | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 4/8/2025 |
BHST BioHarvest Sciences | $5.90
+5.2% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of BioHarvest Sciences (NASDAQ:BHST) on 4/8/2025 |
MVST Microvast | $1.70
-1.7% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of Microvast (NASDAQ:MVST) on 4/8/2025 |
VRCA Verrica Pharmaceuticals | $0.55
+14.2% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst O. Livnat | Neutral -> Neutral | | Medium | View details for HC Wainwright rating of Verrica Pharmaceuticals (NASDAQ:VRCA) on 4/8/2025 |
PCRX Pacira BioSciences | $24.97
+1.7% | 4/8/2025 | Target Raised by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $48.00 -> $65.00 | High | View details for HC Wainwright rating of Pacira BioSciences (NASDAQ:PCRX) on 4/8/2025 |
PRLD Prelude Therapeutics | $0.69
-2.0% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Prelude Therapeutics (NASDAQ:PRLD) on 4/8/2025 |
LEGN Legend Biotech | $32.11
+0.3% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $75.00 -> $75.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 4/8/2025 |
Warning: “DOGE Collapse” imminent (Ad) Elon Strikes Back
You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead. Click here to see what they’re predicting now. |
LXEO Lexeo Therapeutics | $2.14
+8.1% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $23.00 -> $23.00 | High | View details for HC Wainwright rating of Lexeo Therapeutics (NASDAQ:LXEO) on 4/8/2025 |
PHIO Phio Pharmaceuticals | $2.20
+26.4% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Phio Pharmaceuticals (NASDAQ:PHIO) on 4/8/2025 |
RYTM Rhythm Pharmaceuticals | $60.14
+1.0% | 4/8/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $70.00 -> $80.00 | High | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 4/8/2025 |
VNRX VolitionRx | $0.50
+2.9% | 4/8/2025 | Initiated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $2.50 -> $2.50 | High | View details for HC Wainwright rating of VolitionRx (NYSE:VNRX) on 4/8/2025 |
OPK OPKO Health | $1.42
+0.4% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $3.00 -> $3.00 | Low | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 4/7/2025 |
CRDL Cardiol Therapeutics | $1.03
+7.6% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $9.00 -> $9.00 | Low | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 4/7/2025 |
ANRO Alto Neuroscience | $2.11
-0.9% | 4/7/2025 | Initiated by | HC Wainwright | Analyst Patrick Trucchio | Buy | $10.00 | High | View details for HC Wainwright rating of Alto Neuroscience (NYSE:ANRO) on 4/7/2025 |
FLD FTAC Emerald Acquisition | $3.24
+20.4% | 4/7/2025 | Initiated by | HC Wainwright | Analyst Kevin Dede | Buy | $7.00 | Medium | View details for HC Wainwright rating of FTAC Emerald Acquisition (NASDAQ:FLD) on 4/7/2025 |
ZURA Zura Bio | $1.12
-7.4% | 4/3/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | | High | View details for HC Wainwright rating of Zura Bio (NASDAQ:ZURA) on 4/3/2025 |
AURA Aura Biosciences | $5.45
+2.8% | 3/25/2025 | Target Set by | HC Wainwright | Analyst Edward White | | $25.00 | Medium | View details for HC Wainwright rating of Aura Biosciences (NASDAQ:AURA) on 3/25/2025 |
SGMO Sangamo Therapeutics | $0.75
+4.5% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 4/7/2025 |
ARVN Arvinas | $7.40
+6.5% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $81.00 -> $81.00 | Low | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 4/7/2025 |
DGXX Digihost Technology | $1.03
+7.3% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $2.50 -> $2.50 | High | View details for HC Wainwright rating of Digihost Technology (NASDAQ:DGXX) on 4/7/2025 |
BEAM Beam Therapeutics | $17.00
+9.9% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 4/7/2025 |
AVXL Anavex Life Sciences | $8.82
-0.5% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $42.00 -> $42.00 | Medium | View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 4/7/2025 |
BCAX Bicara Therapeutics | $11.38
+5.7% | 4/7/2025 | Target Lowered by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $45.00 -> $44.00 | High | View details for HC Wainwright rating of Bicara Therapeutics (NASDAQ:BCAX) on 4/7/2025 |
KSCP Knightscope | $3.00
+3.1% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $16.00 -> $12.00 | High | View details for HC Wainwright rating of Knightscope (NASDAQ:KSCP) on 4/7/2025 |
ANGO AngioDynamics | $9.79
+5.4% | 4/7/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $15.00 -> $16.00 | Medium | View details for HC Wainwright rating of AngioDynamics (NASDAQ:ANGO) on 4/7/2025 |
IONS Ionis Pharmaceuticals | $28.68
+2.8% | 4/7/2025 | Initiated by | HC Wainwright | Analyst Mitchell Kapoor | Buy | $45.00 | Medium | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/7/2025 |
SRTS Sensus Healthcare | $4.79
+3.9% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $12.00 -> $12.00 | Low | View details for HC Wainwright rating of Sensus Healthcare (NASDAQ:SRTS) on 4/4/2025 |
ANY Sphere 3D | $0.52
+12.2% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of Sphere 3D (NASDAQ:ANY) on 4/4/2025 |
ALDX Aldeyra Therapeutics | $2.12
+11.0% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 4/4/2025 |
RNXT RenovoRx | $0.84
+9.4% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of RenovoRx (NASDAQ:RNXT) on 4/4/2025 |
CYTK Cytokinetics | $39.81
+3.0% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $120.00 -> $120.00 | High | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 4/4/2025 |
CMPX Compass Therapeutics | $1.72
+1.5% | 4/4/2025 | Target Raised by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $10.00 -> $24.00 | Medium | View details for HC Wainwright rating of Compass Therapeutics (NASDAQ:CMPX) on 4/4/2025 |
PHGE BiomX | $0.55
-25.7% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for HC Wainwright rating of BiomX (NYSEMKT:PHGE) on 4/4/2025 |
AKBA Akebia Therapeutics | $1.83
+10.9% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $7.50 -> $7.50 | High | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 4/4/2025 |
VANI Vivani Medical | $1.04
+2.0% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Vivani Medical (NASDAQ:VANI) on 4/4/2025 |
KALA KALA BIO | $3.49
+3.6% | 4/4/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for HC Wainwright rating of KALA BIO (NASDAQ:KALA) on 4/4/2025 |
OBIO Orchestra BioMed | $2.80
-6.0% | 4/4/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $14.00 -> $12.00 | High | View details for HC Wainwright rating of Orchestra BioMed (NASDAQ:OBIO) on 4/4/2025 |
IMAB I-Mab | $0.96
+42.8% | 4/4/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $8.00 -> $7.00 | High | View details for HC Wainwright rating of I-Mab (NASDAQ:IMAB) on 4/4/2025 |
ALT Altimmune | $4.63
+5.0% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 4/3/2025 |
ARQT Arcutis Biotherapeutics | $12.94
+2.8% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $19.00 -> $19.00 | Medium | View details for HC Wainwright rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 4/3/2025 |
DAWN Day One Biopharmaceuticals | $7.22
+1.4% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $36.00 -> $36.00 | Low | View details for HC Wainwright rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 4/3/2025 |
CTSO Cytosorbents | $0.99
+1.9% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst Sean Lee | Neutral -> Neutral | $1.00 -> $1.00 | Low | View details for HC Wainwright rating of Cytosorbents (NASDAQ:CTSO) on 4/3/2025 |
KAPA Kairos Pharma | $0.95
-5.7% | 4/3/2025 | Initiated by | HC Wainwright | Analyst Joseph Pantginis | Buy | $12.00 | N/A | View details for HC Wainwright rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 4/3/2025 |
ADAG Adagene | $1.52
-0.7% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst Arthur He | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of Adagene (NASDAQ:ADAG) on 4/3/2025 |
RANI Rani Therapeutics | $1.23
+3.4% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for HC Wainwright rating of Rani Therapeutics (NASDAQ:RANI) on 4/3/2025 |
IPSC Century Therapeutics | $0.50
+4.0% | 4/3/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $5.00 -> $2.00 | Medium | View details for HC Wainwright rating of Century Therapeutics (NASDAQ:IPSC) on 4/3/2025 |
ZURA Zura Bio | $1.12
-7.4% | 4/3/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Neutral | $5.00 -> $3.00 | High | View details for HC Wainwright rating of Zura Bio (NASDAQ:ZURA) on 4/3/2025 |
MGX Metagenomi | $1.52
+2.7% | 4/3/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $14.00 -> $7.00 | High | View details for HC Wainwright rating of Metagenomi (NASDAQ:MGX) on 4/3/2025 |
KYTX Kyverna Therapeutics | $2.23
+8.3% | 4/3/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Neutral | $6.00 -> $4.00 | Low | View details for HC Wainwright rating of Kyverna Therapeutics (NASDAQ:KYTX) on 4/3/2025 |
AXSM Axsome Therapeutics | $103.53
+5.6% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $200.00 -> $200.00 | High | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 4/3/2025 |
ACIU AC Immune | $1.52
-2.6% | 4/3/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 4/3/2025 |
HURA TuHURA Biosciences | $4.20
-0.5% | 4/3/2025 | Target Lowered by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $13.00 -> $12.00 | Low | View details for HC Wainwright rating of TuHURA Biosciences (NASDAQ:HURA) on 4/3/2025 |
ALNY Alnylam Pharmaceuticals | $240.01
+0.9% | 4/2/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $500.00 -> $500.00 | Medium | View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 4/2/2025 |
NRIX Nurix Therapeutics | $9.85
+7.8% | 4/2/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $36.00 -> $36.00 | High | View details for HC Wainwright rating of Nurix Therapeutics (NASDAQ:NRIX) on 4/2/2025 |
MDAI Spectral AI | $1.25
+1.6% | 4/2/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $3.50 -> $3.50 | Medium | View details for HC Wainwright rating of Spectral AI (NASDAQ:MDAI) on 4/2/2025 |
SRPT Sarepta Therapeutics | $54.63
+7.1% | 4/2/2025 | Upgraded by | HC Wainwright | Analyst M. Kapoor | Sell -> Neutral | $75.00 -> $75.00 | Medium | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 4/2/2025 |
SRZN Surrozen | $9.49
+5.4% | 4/2/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $32.00 -> $32.00 | High | View details for HC Wainwright rating of Surrozen (NASDAQ:SRZN) on 4/2/2025 |
Warning: “DOGE Collapse” imminent (Ad) Elon Strikes Back
You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead. Click here to see what they’re predicting now. |
MLYS Mineralys Therapeutics | $13.92
+3.9% | 4/2/2025 | Target Raised by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $30.00 -> $42.00 | Low | View details for HC Wainwright rating of Mineralys Therapeutics (NASDAQ:MLYS) on 4/2/2025 |
AQST Aquestive Therapeutics | $2.52
+2.0% | 4/2/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 4/2/2025 |
GALT Galectin Therapeutics | $1.34
-0.7% | 4/2/2025 | Reiterated by | HC Wainwright | Analyst E. Arce | Neutral -> Neutral | | High | View details for HC Wainwright rating of Galectin Therapeutics (NASDAQ:GALT) on 4/2/2025 |
CABA Cabaletta Bio | $1.17
-5.3% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 4/1/2025 |
DARE Daré Bioscience | $2.93
-0.3% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Daré Bioscience (NASDAQ:DARE) on 4/1/2025 |
UNCY Unicycive Therapeutics | $0.61
+11.4% | 4/1/2025 | Target Raised by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $4.00 -> $7.50 | High | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 4/1/2025 |
LGO Largo | $1.52
-2.3% | 4/1/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $3.70 -> $3.90 | Medium | View details for HC Wainwright rating of Largo (NYSE:LGO) on 4/1/2025 |
NMG Nouveau Monde Graphite | $1.66
-2.1% | 4/1/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $3.00 -> $2.75 | Low | View details for HC Wainwright rating of Nouveau Monde Graphite (NYSE:NMG) on 4/1/2025 |
RZLV Rezolve AI | $1.14
| 4/1/2025 | Initiated by | HC Wainwright | Analyst Scott Buck | Buy | $4.00 | High | View details for HC Wainwright rating of Rezolve AI (NASDAQ:RZLV) on 4/1/2025 |
GRYP Gryphon Digital Mining | $0.16
+1.5% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Neutral -> Neutral | | High | View details for HC Wainwright rating of Gryphon Digital Mining (NASDAQ:GRYP) on 4/1/2025 |
SABS SAB Biotherapeutics | $1.39
+13.0% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/1/2025 |
ATNM Actinium Pharmaceuticals | $1.32
+1.5% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 -> $4.00 | Medium | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSE:ATNM) on 4/1/2025 |
CALC CalciMedica | $1.63
+6.1% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | Medium | View details for HC Wainwright rating of CalciMedica (NASDAQ:CALC) on 4/1/2025 |
PHGE BiomX | $0.56
+3.7% | 4/1/2025 | Target Raised by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $2.00 -> $21.00 | N/A | View details for HC Wainwright rating of BiomX (NYSEAMERICAN:PHGE) on 4/1/2025 |
MNPR Monopar Therapeutics | $37.49
+7.5% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Monopar Therapeutics (NASDAQ:MNPR) on 4/1/2025 |
IRD Opus Genetics | $0.82
+16.1% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $8.00 -> $8.00 | High | View details for HC Wainwright rating of Opus Genetics (NASDAQ:IRD) on 4/1/2025 |
FBLG FibroBiologics | $0.98
+10.1% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of FibroBiologics (NASDAQ:FBLG) on 4/1/2025 |
CELC Celcuity | $9.75
+5.6% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $27.00 -> $27.00 | High | View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 4/1/2025 |
ADAP Adaptimmune Therapeutics | $0.23
+5.2% | 4/1/2025 | Target Lowered by | HC Wainwright | Analyst Arthur He | Buy -> Buy | $3.50 -> $3.00 | High | View details for HC Wainwright rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 4/1/2025 |
EBS Emergent BioSolutions | $4.61
+5.0% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Emergent BioSolutions (NYSE:EBS) on 4/1/2025 |
VNDA Vanda Pharmaceuticals | $4.36
+5.6% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $20.00 -> $20.00 | Medium | View details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 4/1/2025 |
IOBT IO Biotech | $0.90
+4.8% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of IO Biotech (NASDAQ:IOBT) on 4/1/2025 |
KROS Keros Therapeutics | $12.74
+4.6% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Keros Therapeutics (NASDAQ:KROS) on 4/1/2025 |
PVLA Palvella Therapeutics | $24.44
+12.3% | 4/1/2025 | Reiterated by | HC Wainwright | Analyst A. Fein | Buy -> Buy | $38.00 -> $38.00 | High | View details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 4/1/2025 |
BNTX BioNTech | $102.34
+6.0% | 4/1/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $150.00 -> $145.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 4/1/2025 |
CRIS Curis | $1.29
+10.3% | 3/31/2025 | Target Lowered by | HC Wainwright | Analyst Edward White | Buy -> Buy | $20.00 -> $16.00 | High | View details for HC Wainwright rating of Curis (NASDAQ:CRIS) on 3/31/2025 |
CNTB Connect Biopharma | $0.65
+4.1% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $8.00 -> $8.00 | High | View details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 3/31/2025 |
VALN Valneva | $7.05
+12.1% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 3/31/2025 |
CORT Corcept Therapeutics | $67.43
-1.7% | 3/31/2025 | Target Raised by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $115.00 -> $150.00 | High | View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 3/31/2025 |
TNYA Tenaya Therapeutics | $0.49
-0.6% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/31/2025 |
BMEA Biomea Fusion | $1.62
-7.4% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 3/31/2025 |
CATX Perspective Therapeutics | $2.05
+5.1% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Perspective Therapeutics (NYSE:CATX) on 3/31/2025 |
ADCT ADC Therapeutics | $1.21
-1.2% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $8.00 -> $8.00 | High | View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 3/31/2025 |
NNE Nano Nuclear Energy | $23.44
+0.7% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst S. Joshi | Buy -> Buy | $50.00 -> $50.00 | High | View details for HC Wainwright rating of Nano Nuclear Energy (NASDAQ:NNE) on 3/31/2025 |
IPA ImmunoPrecise Antibodies | $0.46
+6.0% | 3/31/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $7.00 -> $5.00 | Medium | View details for HC Wainwright rating of ImmunoPrecise Antibodies (NASDAQ:IPA) on 3/31/2025 |
CGON CG Oncology | $20.06
+4.0% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $75.00 -> $75.00 | High | View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 3/31/2025 |
LVTX LAVA Therapeutics | $1.16
+6.4% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst A. He | Neutral -> Neutral | $1.50 -> $1.50 | Medium | View details for HC Wainwright rating of LAVA Therapeutics (NASDAQ:LVTX) on 3/31/2025 |
BCAB BioAtla | $0.32
+4.2% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst A. He | Neutral -> Neutral | | High | View details for HC Wainwright rating of BioAtla (NASDAQ:BCAB) on 3/31/2025 |
GNLX Genelux | $2.42
-1.6% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Genelux (NASDAQ:GNLX) on 3/31/2025 |
KOD Kodiak Sciences | $2.18
| 3/31/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Neutral -> Neutral | $3.00 -> $3.00 | High | View details for HC Wainwright rating of Kodiak Sciences (NASDAQ:KOD) on 3/31/2025 |
HLVX HilleVax | $1.68
+0.6% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Neutral -> Neutral | $2.00 -> $2.00 | High | View details for HC Wainwright rating of HilleVax (NASDAQ:HLVX) on 3/31/2025 |
HROW Harrow | $24.40
+1.3% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $57.00 -> $57.00 | Low | View details for HC Wainwright rating of Harrow (NASDAQ:HROW) on 3/31/2025 |
CLSD Clearside Biomedical | $0.80
+4.6% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $6.00 -> $6.00 | Medium | View details for HC Wainwright rating of Clearside Biomedical (NASDAQ:CLSD) on 3/31/2025 |
SLNO Soleno Therapeutics | $70.00
+4.1% | 3/31/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $70.00 -> $100.00 | Medium | View details for HC Wainwright rating of Soleno Therapeutics (NASDAQ:SLNO) on 3/31/2025 |
AVXL Anavex Life Sciences | $8.82
-0.5% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $42.00 -> $42.00 | Medium | View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 3/31/2025 |
ACOG Alpha Cognition | $4.83
+10.3% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $20.00 -> $20.00 | High | View details for HC Wainwright rating of Alpha Cognition (NASDAQ:ACOG) on 3/31/2025 |
TRDA Entrada Therapeutics | $7.92
+0.3% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Entrada Therapeutics (NASDAQ:TRDA) on 3/31/2025 |
TYRA Tyra Biosciences | $8.43
+5.9% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 3/31/2025 |
ALGS Aligos Therapeutics | $4.61
+13.0% | 3/31/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $70.00 -> $70.00 | High | View details for HC Wainwright rating of Aligos Therapeutics (NASDAQ:ALGS) on 3/31/2025 |
CODX Co-Diagnostics | $0.36
-1.8% | 3/28/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Neutral -> Neutral | $1.50 -> $1.00 | Low | View details for HC Wainwright rating of Co-Diagnostics (NASDAQ:CODX) on 3/28/2025 |
Why War with China Start in 128 Days (Ad) The clock is ticking.
Those who aren't prepared could lose everything.
I've identified 43 investments we believe are in immediate danger. There's a good chance you own at least one of these through a brokerage account, mutual fund, 401K, |
IKT Inhibikase Therapeutics | $2.00
-3.4% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst E. White | Neutral -> Neutral | | High | View details for HC Wainwright rating of Inhibikase Therapeutics (NYSE:IKT) on 3/28/2025 |
LXRX Lexicon Pharmaceuticals | $0.53
+3.6% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for HC Wainwright rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 3/28/2025 |
MIST Milestone Pharmaceuticals | $0.83
+7.8% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for HC Wainwright rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 3/28/2025 |
ABOS Acumen Pharmaceuticals | $1.10
-0.9% | 3/28/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $15.00 -> $11.00 | High | View details for HC Wainwright rating of Acumen Pharmaceuticals (NASDAQ:ABOS) on 3/28/2025 |
IVA Inventiva | $3.29
-2.1% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of Inventiva (NASDAQ:IVA) on 3/28/2025 |
GEVO Gevo | $1.16
+1.8% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 3/28/2025 |
ICCM IceCure Medical | $1.16
+3.1% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $2.50 -> $2.50 | Low | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 3/28/2025 |
USAS Americas Silver | $0.58
+7.6% | 3/28/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $0.90 -> $1.00 | N/A | View details for HC Wainwright rating of Americas Silver (NYSEAMERICAN:USAS) on 3/28/2025 |
WKSP Worksport | $3.15
-0.6% | 3/28/2025 | Target Raised by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $1.50 -> $11.50 | Medium | View details for HC Wainwright rating of Worksport (NASDAQ:WKSP) on 3/28/2025 |
SVRA Savara | $2.90
-0.7% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $6.00 -> $6.00 | Medium | View details for HC Wainwright rating of Savara (NASDAQ:SVRA) on 3/28/2025 |
DTIL Precision BioSciences | $4.46
+1.4% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $60.00 -> $60.00 | Low | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 3/28/2025 |
EDAP Edap Tms | $1.38
-2.8% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $19.00 -> $19.00 | Low | View details for HC Wainwright rating of Edap Tms (NASDAQ:EDAP) on 3/28/2025 |
IPHA Innate Pharma | $1.90
+1.3% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $11.50 -> $11.50 | Low | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 3/28/2025 |
PSTV Plus Therapeutics | $0.64
-14.7% | 3/28/2025 | Target Lowered by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $8.00 -> $5.50 | High | View details for HC Wainwright rating of Plus Therapeutics (NASDAQ:PSTV) on 3/28/2025 |
TPST Tempest Therapeutics | $6.96
+11.9% | 3/28/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $611.00 -> $208.00 | High | View details for HC Wainwright rating of Tempest Therapeutics (NASDAQ:TPST) on 3/28/2025 |
XOMA XOMA | $20.28
+1.6% | 3/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $104.00 -> $104.00 | Medium | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 3/28/2025 |
FEMY Femasys | $1.14
| 3/28/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 3/28/2025 |
DRRX DURECT | $0.73
-2.8% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Neutral -> Neutral | | Medium | View details for HC Wainwright rating of DURECT (NASDAQ:DRRX) on 3/27/2025 |
BITF Bitfarms | $0.82
+2.2% | 3/27/2025 | Target Lowered by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $4.00 -> $3.50 | Low | View details for HC Wainwright rating of Bitfarms (NASDAQ:BITF) on 3/27/2025 |
STTK Shattuck Labs | $0.88
-7.9% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Neutral -> Neutral | | High | View details for HC Wainwright rating of Shattuck Labs (NASDAQ:STTK) on 3/27/2025 |
PDSB PDS Biotechnology | $1.08
+4.9% | 3/27/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $21.00 -> $13.00 | Low | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 3/27/2025 |
CAN Canaan | $0.75
+10.9% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of Canaan (NASDAQ:CAN) on 3/27/2025 |
AIRJ Montana Technologies | $5.14
+3.8% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Montana Technologies (NASDAQ:AIRJ) on 3/27/2025 |
USIO Usio | $1.46
+5.8% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Usio (NASDAQ:USIO) on 3/27/2025 |
ITRG Integra Resources | $1.69
+9.0% | 3/27/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.00 -> $2.75 | N/A | View details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 3/27/2025 |
XFOR X4 Pharmaceuticals | $0.20
-2.5% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $1.50 -> $1.50 | Medium | View details for HC Wainwright rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 3/27/2025 |
LPTX Leap Therapeutics | $0.34
+5.2% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Neutral -> Neutral | | Medium | View details for HC Wainwright rating of Leap Therapeutics (NASDAQ:LPTX) on 3/27/2025 |
RNXT RenovoRx | $0.84
+9.4% | 3/27/2025 | Initiated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy | $3.00 | Low | View details for HC Wainwright rating of RenovoRx (NASDAQ:RNXT) on 3/27/2025 |
NKTX Nkarta | $1.70
+7.9% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of Nkarta (NASDAQ:NKTX) on 3/27/2025 |
EXEL Exelixis | $35.74
+1.2% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $40.00 -> $40.00 | Medium | View details for HC Wainwright rating of Exelixis (NASDAQ:EXEL) on 3/27/2025 |
ZNTL Zentalis Pharmaceuticals | $1.22
-0.8% | 3/27/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 3/27/2025 |
NYXH Nyxoah | $5.98
-2.8% | 3/26/2025 | Target Lowered by | HC Wainwright | Analyst Edward White | Buy -> Buy | $17.00 -> $15.00 | High | View details for HC Wainwright rating of Nyxoah (NASDAQ:NYXH) on 3/26/2025 |
VANI Vivani Medical | $1.04
+2.0% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Vivani Medical (NASDAQ:VANI) on 3/26/2025 |
WVE Wave Life Sciences | $6.00
+6.2% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of Wave Life Sciences (NASDAQ:WVE) on 3/26/2025 |
VKTX Viking Therapeutics | $24.57
+10.6% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $102.00 -> $102.00 | Medium | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2025 |
ATOS Atossa Therapeutics | $0.63
-1.8% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 3/26/2025 |
FUFU BitFuFu | $4.34
-0.9% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst K. Dede | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of BitFuFu (NASDAQ:FUFU) on 3/26/2025 |
CRVS Corvus Pharmaceuticals | $3.03
+1.7% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst S. Lee | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 3/26/2025 |
ACRV Acrivon Therapeutics | $1.50
-7.4% | 3/26/2025 | Target Lowered by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $22.00 -> $19.00 | High | View details for HC Wainwright rating of Acrivon Therapeutics (NASDAQ:ACRV) on 3/26/2025 |
IMNN Imunon | $0.87
+2.4% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of Imunon (NASDAQ:IMNN) on 3/26/2025 |
ARTV Artiva Biotherapeutics | $1.96
-1.0% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst E. White | Buy -> Buy | $20.00 -> $20.00 | High | View details for HC Wainwright rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 3/26/2025 |
ALMS Alumis | $5.39
-16.8% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 3/26/2025 |
LXEO Lexeo Therapeutics | $2.14
+8.1% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $23.00 -> $23.00 | High | View details for HC Wainwright rating of Lexeo Therapeutics (NASDAQ:LXEO) on 3/26/2025 |
MURA Mural Oncology | $1.03
| 3/26/2025 | Target Lowered by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $18.00 -> $6.00 | High | View details for HC Wainwright rating of Mural Oncology (NASDAQ:MURA) on 3/26/2025 |
IVVD Invivyd | $0.53
-4.4% | 3/26/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 3/26/2025 |
SMTI Sanara MedTech | $29.96
+3.1% | 3/26/2025 | Target Raised by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $50.00 -> $51.00 | High | View details for HC Wainwright rating of Sanara MedTech (NASDAQ:SMTI) on 3/26/2025 |
FNV Franco-Nevada | $169.18
+1.8% | 3/26/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $165.00 -> $180.00 | Medium | View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 3/26/2025 |
SAVA Cassava Sciences | $1.34
+5.5% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst V. Bernardino | Neutral -> Neutral | $2.00 -> $2.00 | High | View details for HC Wainwright rating of Cassava Sciences (NASDAQ:SAVA) on 3/25/2025 |
GNLX Genelux | $2.42
-1.6% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Genelux (NASDAQ:GNLX) on 3/25/2025 |
ATNM Actinium Pharmaceuticals | $1.32
+1.5% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSE:ATNM) on 3/25/2025 |
Now I look stupid. Real stupid... (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
BOLT Bolt Biotherapeutics | $0.37
+14.3% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Neutral -> Neutral | | High | View details for HC Wainwright rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 3/25/2025 |
OPT Opthea | $3.41
+7.2% | 3/25/2025 | Downgraded by | HC Wainwright | Analyst Matthew Caufield | Buy -> Neutral | $12.00 -> $2.00 | Low | View details for HC Wainwright rating of Opthea (NASDAQ:OPT) on 3/25/2025 |
MAG MAG Silver | $15.82
+5.5% | 3/25/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $21.00 -> $22.00 | N/A | View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 3/25/2025 |
CGON CG Oncology | $20.06
+4.0% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $75.00 -> $75.00 | Medium | View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 3/25/2025 |
LRMR Larimar Therapeutics | $1.87
+3.3% | 3/25/2025 | Target Raised by | HC Wainwright | Analyst E. White | Buy -> Buy | $15.00 -> $16.00 | Medium | View details for HC Wainwright rating of Larimar Therapeutics (NASDAQ:LRMR) on 3/25/2025 |
MGNX MacroGenics | $1.27
-1.6% | 3/25/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Neutral -> Neutral | $4.00 -> $2.00 | High | View details for HC Wainwright rating of MacroGenics (NASDAQ:MGNX) on 3/25/2025 |
ANIX Anixa Biosciences | $2.65
+2.7% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Anixa Biosciences (NASDAQ:ANIX) on 3/25/2025 |
VERV Verve Therapeutics | $4.12
+26.4% | 3/25/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Verve Therapeutics (NASDAQ:VERV) on 3/25/2025 |
NGNE Neurogene | $10.89
-1.0% | 3/25/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $55.00 -> $50.00 | High | View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 3/25/2025 |
PLUG Plug Power | $1.06
-6.2% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of Plug Power (NASDAQ:PLUG) on 3/24/2025 |
CLNN Clene | $3.08
+1.7% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $31.00 -> $31.00 | High | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 3/24/2025 |
BMEA Biomea Fusion | $1.62
-7.4% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 3/24/2025 |
MBRX Moleculin Biotech | $0.83
+3.7% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of Moleculin Biotech (NASDAQ:MBRX) on 3/24/2025 |
UBX Unity Biotechnology | $0.97
-2.0% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $8.00 -> $4.00 | N/A | View details for HC Wainwright rating of Unity Biotechnology (NASDAQ:UBX) on 3/24/2025 |
AURA Aura Biosciences | $5.45
+2.8% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of Aura Biosciences (NASDAQ:AURA) on 3/24/2025 |
ASMB Assembly Biosciences | $10.20
+12.3% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Neutral -> Neutral | | High | View details for HC Wainwright rating of Assembly Biosciences (NASDAQ:ASMB) on 3/24/2025 |
ABEO Abeona Therapeutics | $4.95
+7.6% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Abeona Therapeutics (NASDAQ:ABEO) on 3/24/2025 |
BNTC Benitec Biopharma | $13.27
+5.1% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $28.00 -> $28.00 | High | View details for HC Wainwright rating of Benitec Biopharma (NASDAQ:BNTC) on 3/24/2025 |
CGTX Cognition Therapeutics | $0.39
+11.6% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $6.00 -> $5.00 | High | View details for HC Wainwright rating of Cognition Therapeutics (NASDAQ:CGTX) on 3/24/2025 |
ENLV Enlivex Therapeutics | $0.89
-1.3% | 3/24/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $6.00 -> $7.00 | High | View details for HC Wainwright rating of Enlivex Therapeutics (NASDAQ:ENLV) on 3/24/2025 |
RMTI Rockwell Medical | $1.05
-1.4% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $7.00 -> $3.00 | High | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 3/24/2025 |
RYTM Rhythm Pharmaceuticals | $60.14
+1.0% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $70.00 -> $70.00 | High | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 3/24/2025 |
FLUX Flux Power | $1.48
-0.7% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $15.00 -> $8.00 | High | View details for HC Wainwright rating of Flux Power (NASDAQ:FLUX) on 3/24/2025 |
PHUN Phunware | $2.65
+1.5% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst S. Buck | Neutral -> Neutral | $6.00 -> $3.00 | Medium | View details for HC Wainwright rating of Phunware (NASDAQ:PHUN) on 3/24/2025 |
COLL Collegium Pharmaceutical | $26.73
+1.6% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $50.00 -> $50.00 | High | View details for HC Wainwright rating of Collegium Pharmaceutical (NASDAQ:COLL) on 3/24/2025 |
VSTM Verastem | $4.78
+3.0% | 3/24/2025 | Target Raised by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $7.00 -> $10.00 | Medium | View details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 3/24/2025 |
MTVA MetaVia | $1.84
+26.9% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for HC Wainwright rating of MetaVia (NASDAQ:MTVA) on 3/21/2025 |
BRNS Barinthus Biotherapeutics | $0.70
-0.6% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 3/21/2025 |
YMAB Y-mAbs Therapeutics | $4.93
+2.1% | 3/21/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $22.00 -> $12.00 | Medium | View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 3/21/2025 |
LGVN Longeveron | $1.45
-3.0% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Longeveron (NASDAQ:LGVN) on 3/21/2025 |
EBS Emergent BioSolutions | $4.61
+5.0% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $15.00 -> $15.00 | Low | View details for HC Wainwright rating of Emergent BioSolutions (NYSE:EBS) on 3/21/2025 |
ERAS Erasca | $1.24
| 3/21/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 3/21/2025 |
MOGO Mogo | $0.85
+4.5% | 3/21/2025 | Target Lowered by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $6.00 -> $4.00 | Low | View details for HC Wainwright rating of Mogo (NASDAQ:MOGO) on 3/21/2025 |
IDN Intellicheck | $2.41
+2.1% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Intellicheck (NYSE:IDN) on 3/21/2025 |
PPTA Perpetua Resources | $13.74
+16.1% | 3/21/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $25.00 -> $28.00 | High | View details for HC Wainwright rating of Perpetua Resources (NASDAQ:PPTA) on 3/21/2025 |
UAMY United States Antimony | $3.14
+12.5% | 3/21/2025 | Target Raised by | HC Wainwright | Analyst H. Ihle | Buy -> Buy | $2.50 -> $2.60 | High | View details for HC Wainwright rating of United States Antimony (NYSE:UAMY) on 3/21/2025 |
AMPX Amprius Technologies | $2.41
-0.8% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Amprius Technologies (NYSE:AMPX) on 3/21/2025 |
CBUS Cibus | $1.66
-8.6% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of Cibus (NASDAQ:CBUS) on 3/21/2025 |
VALN Valneva | $7.05
+12.1% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $17.00 -> $17.00 | Low | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 3/21/2025 |
IFRX InflaRx | $0.98
+6.0% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 3/21/2025 |
ELEV Elevation Oncology | $0.29
+4.9% | 3/21/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $6.00 -> $1.00 | High | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 3/21/2025 |
VOR Vor Biopharma | $0.69
-1.3% | 3/21/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $17.50 -> $13.00 | High | View details for HC Wainwright rating of Vor Biopharma (NYSE:VOR) on 3/21/2025 |
CNTX Context Therapeutics | $0.85
+9.6% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Context Therapeutics (NASDAQ:CNTX) on 3/21/2025 |
ELVN Enliven Therapeutics | $17.19
+4.1% | 3/21/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $37.00 -> $39.00 | High | View details for HC Wainwright rating of Enliven Therapeutics (NASDAQ:ELVN) on 3/21/2025 |
OPTN OptiNose | $9.10
+0.3% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Neutral | $18.00 -> $9.00 | Low | View details for HC Wainwright rating of OptiNose (NASDAQ:OPTN) on 3/21/2025 |
AVTX Avalo Therapeutics | $5.38
+9.8% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst E. White | Neutral -> Neutral | | Low | View details for HC Wainwright rating of Avalo Therapeutics (NASDAQ:AVTX) on 3/20/2025 |
ESPR Esperion Therapeutics | $1.00
-2.0% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | Low | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 3/20/2025 |
PHAR Pharming Group | $8.00
-0.6% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $37.00 -> $37.00 | Low | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 3/20/2025 |
PGEN Precigen | $1.40
| 3/20/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Precigen (NASDAQ:PGEN) on 3/20/2025 |
SCPH scPharmaceuticals | $2.58
+11.2% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of scPharmaceuticals (NASDAQ:SCPH) on 3/20/2025 |
MDWD MediWound | $16.59
+1.3% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 3/20/2025 |
KRRO Korro Bio | $12.84
-0.5% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $115.00 -> $115.00 | High | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 3/20/2025 |
ALMS Alumis | $5.39
-16.8% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $19.00 -> $15.00 | High | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 3/20/2025 |
LQDA Liquidia | $13.83
+2.7% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $29.00 -> $29.00 | High | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 3/20/2025 |
PMVP PMV Pharmaceuticals | $0.95
+9.2% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $5.00 -> $5.00 | Low | View details for HC Wainwright rating of PMV Pharmaceuticals (NASDAQ:PMVP) on 3/20/2025 |
NRXP NRx Pharmaceuticals | $2.03
-1.0% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $19.00 -> $19.00 | High | View details for HC Wainwright rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/20/2025 |
FEMY Femasys | $1.14
| 3/19/2025 | Target Raised by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $12.00 -> $15.00 | Medium | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 3/19/2025 |
DTIL Precision BioSciences | $4.46
+1.4% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $60.00 -> $60.00 | Low | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 3/19/2025 |
ATAI Atai Life Sciences | $1.38
+7.0% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Atai Life Sciences (NASDAQ:ATAI) on 3/19/2025 |
IMVT Immunovant | $15.43
+5.1% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $51.00 -> $51.00 | High | View details for HC Wainwright rating of Immunovant (NASDAQ:IMVT) on 3/19/2025 |
